Arthritis News and Research

Latest Arthritis News and Research

Mustard and garlic kick linked to single pain receptor

A single pain receptor is solely responsible for the kick delivered by mustard oil and garlic, according to research in the Cell. Mustard oil is the active ingredient in mustard and in the pungent green sushi condiment known as wasabi.

28 Mar 2006

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Schering-Plough Corporation today announced that the Therapeutic Goods Administration of the Department of Health and Ageing in Australia has revised the indication of Remicade (infliximab) to include the treatment of early rheumatoid arthritis (RA) and approved a new indication for psoriatic arthritis (PsA).

23 Mar 2006

Stem cells, gene therapy and allograft applications show promise for treating orthopaedic conditions

Recent advances in gene therapy, stem cells and other promising applications are offering new hope for patients and helping orthopaedic surgeons provide state-of-the-art treatment for various frame-related conditions.

23 Mar 2006

Atorvastatin could prove an effective therapy for multiple sclerosis

Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).

20 Mar 2006

Study to Rituximab's potential to preserve insulin production in newly diagnosed type 1 diabetics

A drug used to treat lymphoma, rheumatoid arthritis and other immune disorders may enable newly-diagnosed type 1 diabetics to save some of their pancreas function and thereby reduce their susceptibility to long-term complications.

20 Mar 2006

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

University of Michigan scientists have found a common genetic variation in an immune system gene that makes people much more likely to develop psoriasis - a disfiguring inflammatory skin disease.

19 Mar 2006

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

EntreMed has announced the issuance of U.S. Patent No. 7,012,070 covering methods of treatment for a broad range of indications with its lead clinical-stage compound, 2-methoxyestradiol (2ME2).

17 Mar 2006

Drug trial nightmare - two still critically ill

In the drug trial nightmare which has left six men very ill in a London Hospital two remain in intensive care and are not expected to make any early improvement, according to their doctor Ganesh Suntharalingham, Northwick Park Hospital's Clinical Director of Intensive Care.

17 Mar 2006

Drug trial goes wrong and six end up intensive care

After taking part in a clinical trial of a new drug six men are now seriously ill in a north London hospital in the UK.

15 Mar 2006

RvE1 protects from inflammation and bone loss in experimental periodontitis

Gum disease is initiated by bacteria populating dental plaque and may eventually result in tissue and tooth loss.

13 Mar 2006

Rheumatoid arthritis does not increase risk of hearing loss

Mayo Clinic researchers have found that people with rheumatoid arthritis are no more likely to have hearing loss than other members of the general population.

9 Mar 2006

UCB submits application to FDA for new treatment in Crohn's disease

UCB has announced the submission of a Biologics License Application (BLA) to the United States Food and Drug Administration (FDA) for the approval of CIMZIA (certolizumab pegol, CDP870) for the treatment of patients with Crohn's disease.

6 Mar 2006

FDA approves Rituxan (Rituximab)

Rituxan is the first treatment for RA that selectively targets immune cells known as CD20-positive B-cells. Through this unique mechanism of action, Rituxan may affect multiple pathways by which B-cells are believed to contribute to the initiation and development of RA.

1 Mar 2006

Link between rheumatoid arthritis and cancer examined

Rheumatoid arthritis is an inflammatory disease of the immune system and is thought to be linked to an increased risk of cancers of the lymphatic system.

28 Feb 2006

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

A second course of methotrexate, the most commonly used drug to treat rheumatoid arthritis, is effective in nearly half of studied patients for whom a previous treatment with the drug was ineffective.

27 Feb 2006

New generation gold-based drugs for treating rheumatoid arthritis

Gold compounds have been used for the treatment of rheumatoid arthritis and other autoimmune diseases for more than 75 years, but until now, how the metals work has been a mystery.

27 Feb 2006

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

An inflammatory disease of the immune system, rheumatoid arthritis (RA) is associated with increased occurrence of lymphoma--or cancers of the lymphatic system, which plays an integral role in the body's ability to fight infection.

27 Feb 2006

Study associates meniscal damage with advanced cartilage loss in early osteoarthritis

Cartilage loss is a major component of osteoarthritis (OA), a joint disease that affects over 20 million Americans. In knee OA, cartilage loss is influenced by knee injury, as well as obesity and age. Every healthy knee is supported and protected by a pair of meniscus.

27 Feb 2006

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

Offering hope for millions of people who suffer the most from osteoarthritis, a study published in the New England Journal of Medicine (NEJM) has found that the combined use of two dietary supplements - glucosamine and chondroitin - provided significant pain relief from the most common form of arthritis.

24 Feb 2006

New report suggests promising strategies to preserve brain health as people grow older

With the rapid aging of the population, the National Institutes of Health (NIH) is intensifying the search for strategies to preserve brain health as people grow older.

24 Feb 2006

Arthritis News and Research

Latest Arthritis News and Research

Mustard and garlic kick linked to single pain receptor

Remicade (infliximab) gains Australian approval for treatment of early rheumatoid arthritis

Stem cells, gene therapy and allograft applications show promise for treating orthopaedic conditions

Atorvastatin could prove an effective therapy for multiple sclerosis

Study to Rituximab's potential to preserve insulin production in newly diagnosed type 1 diabetics

Discovery of common genetic variation in an immune system gene that makes people much more likely to develop psoriasis

EntreMed announces new U.S. Patent - "Estrogenic Compounds as Anti-Mitotic Agents"

Drug trial nightmare - two still critically ill

Drug trial goes wrong and six end up intensive care

RvE1 protects from inflammation and bone loss in experimental periodontitis

Rheumatoid arthritis does not increase risk of hearing loss

UCB submits application to FDA for new treatment in Crohn's disease

FDA approves Rituxan (Rituximab)

Link between rheumatoid arthritis and cancer examined

Methotrexate re-use in rheumatoid arthritis is frequently effective despite earlier failures

New generation gold-based drugs for treating rheumatoid arthritis

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

Study associates meniscal damage with advanced cartilage loss in early osteoarthritis

Combination of glucosamine and chondroitin sulfate may be effective in some patients with moderate-to-severe knee pain

New report suggests promising strategies to preserve brain health as people grow older

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Arthritis News and Research

Latest Arthritis News and Research

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in